Genetics of venous leg ulcer: An indication to priority of varicose veins treatment?

International Angiology

Volumn 27, Issue 2, 2008, Pages 91-92

  Zamboni, P ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN;

BLOOD EXAMINATION; CARDIOVASCULAR DISEASE; DISEASE PREDISPOSITION; EDITORIAL; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; LEG ULCER; LEG VARICOSIS; PATIENT ASSESSMENT; RECURRENT DISEASE; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT INDICATION;

GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; VARICOSE ULCER; WOUND HEALING;

EID: 44849114201     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 2006;10:1-110.
2. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 2006;166:729-36.
3. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999;19:511-8.
4. Zamboni P, Tognazzo S, Izzo M, Pancaldi F, Scapoli GL, Liboni A et al. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg 2005;42:309-14.
5. Zamboni P, Izzo M, Tognazzo S, Carandina S, De Palma M, Catozzi L et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med 2006;40:1869-73.
6. Gemmati D, Tognazzo S, Serino ML, Fogato L, Carandina S, De Palma M et al. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension. Wound Repair Regen 2004;12:512-7
7. Tognazzo S, Gemmati D, Palazzo A, Catozzi L, Carandina S, Legnaro A et al. Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers. J Vasc Surg 2006;44:815-9.
8. Gemmati D, Tognazzo S, Catozzi L, Federici F, De Palma M, Gianesini S et al. Influence of gene polymorphisms in ulcer healing process after superficial venous surgery. J Vasc Surg 2006;44:554-62.
9. Zamboni P, Gemmati D. Clinical implications of gene polymorphisms in venous leg ulcer: a model in tissue injury and reparative process. Thromb Haemost 2007;98:131-7.
10. Drakesmith H, Sweetland E, Schimanski L, Edwards J, Cowley D, Ashraf M et al. The hemochromatosis protein HFE inhibits iron export from macrophages. PNAS 2002;99:15602-7.
11. Milman N, Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 2003;64:36-47.
12. Nelzen O, Bergqvist D, Lindhagen A. The prevalence of chronic lower-limb ulceration has been understimated: results of a validated population questionnaire. Br J Surg 1996;83:255-8.
13. Cesarone MR, Belcaro G, Nicolaides AN, Geroulakos G, Griffin M, Incandela L et al. 'Real' epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology 2002;53:119-30.
14. Bergan JJ, Schmid-Schonbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med 2006;355:488-98.
15. Lanzara S, Catozzi L, De Palma M, Federici F, Palazzo A, Taeconi G et al. The inflammatory chain in chronic venous disorders and genetic screening for prevention of venous leg ulcers. Acta Phlebol 2006;7:39-44.